India’s devastating Covid-19 crisis is threatening operations at some of its biggest ports, raising concerns. The action could trigger shipping delays that reverberate through global supply chains.

The situation may echo global trade disruptions seen last year after virus restrictions slowed shipments into China. While India accounts for only fraction of the global trade that China does, any delays in offloading vessels and releasing them to their next destination could create supply chain bottlenecks.

India has 21.9 million tons of cargoes scheduled to arrive during May-June’21 but with labor shortages and force majeure at some ports, many of the vessels could see discharge delays. That may have a knock-on effect on scheduled loadings at the exporting countries.

In the global shipping scenario, India’s surging second wave of COVID-19 infections has dealt a hard blow to the global shipping industry as India is one of the largest suppliers of crew. The sudden surge in coronavirus infections and a shortage of vaccines have left ship workers high and dry.

It has sparked travel curbs and restrictions on Indian crews, sending shipping firms scrambling to find replacements.

Global ports are now slamming doors on Indian crew and vessels. Companies are insisting on vaccinated workers and seafarers, spelling bad news for an already stretched maritime sector.

With a growing number of seaports and airports closing their doors to seafarers to and from India, shipping companies say it’s leading to bottlenecks in crew changes. Several companies are temporarily tapping seafarers from other nations to replace Indians scheduled to board ships.

Reference:
https://www.dw.com/en/india-covid-seafarers-shipping/a-57529998
https://economictimes.indiatimes.com/industry/transportation/shipping-/-transport/india-covid-crisis-hits-work-at-its-biggest-ports-as-risk-to-trade-grows/articleshow/82633023.cms

More News
Why US is pushing India to restart Covid vaccine exports
News · 16/09/2021

The United States has been pushing India to restart vaccine exports as it looks to stem the global spread of the Covid pandemic.

READ MORE
Quess Corp launches new vertical to transform healthcare services in India
News · 01/09/2021

Quess Corp, India’s leading business services provider, announced the launch of its new healthcare vertical to address the shortage of healthcare professionals.

READ MORE
China’s Golden Week to trigger new round of void sailings
News · 01/09/2021

The shippers are in for struggle yet another time, with the market buzzing in speculations of liners planning of ‘blank sailing’ during China’s Golden Week holiday in early October to extract maximised profits.

READ MORE
Israel’s COVID-19 vaccine boosters show signs of taming delta variant of coronavirus
News · 01/09/2021

Less than a month into a COVID-19 vaccine booster drive, Israel is seeing signs of an impact on the country’s high infection and severe illness rates fuelled by the fast-spreading delta variant, officials and scientists say.

READ MORE
Blood test can detect more than 50 types of cancer
News · 16/08/2021

Researchers have developed a blood test able to detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, including those aged over 50 with no symptoms.

READ MORE
NUTRICOSMETICS: A Blooming Global Market
News · 16/08/2021

Nutricosmetic is the point at which nutrition and cosmetics meet. The term encompasses the beneficial effects on beauty resulting from consuming nutrients through the use of food supplements.

READ MORE
Amidation of Light Alkanes – High-end Derivatives directly from Natural Gas
News · 16/08/2021

At Last: Separated and Freshly Bound –
Amidation of light alkanes

READ MORE
AstraZeneca (AZ) says its COVID-19 vaccine protects against severe disease caused by variants
News · 02/08/2021

AstraZeneca (AZ) has announced that new real-world data from Canada shows its COVID-19 vaccine – Vaxzevria – was found to be highly effective after one dose against severe disease or hospitalisation caused by the Beta and Delta variants.

READ MORE
EDQM “RTEMIS” pilot project: real-time remote GMP inspections of API manufacturers
News · 02/08/2021

Interruptions to the inspection programme of the European Directorate for the Quality of Medicines & HealthCare (EDQM) due to travel restrictions – made necessary by the COVID-19 pandemic – led to the creation of a system of Real-Time Remote Inspections (RTEMIS).

READ MORE